한글목차

세계 전임상 in-vivo 이미징 시장의 미래는 연구개발 및 신약개발 시장에서 기회와 함께 유망한 것으로 평가되고 있습니다. 세계 전임상 in-vivo 이미징 시장은 2025-2031년 6.2%의 연평균 복합 성장률(CAGR)로 2031년까지 약 15억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 만성질환의 유병률 증가, 비침습적 소동물 이미징 기술에 대한 수요 증가, 전임상 연구 활동에 대한 자금 지원 증가 등입니다.

• Lucintel의 예측에 따르면 예측 기간 중 마이크로 초음파 시스템 부문이 가장 높은 성장세를 보일 것으로 예측됩니다.
• 용도별로는 연구 및 의약품 개발에 대한 모달리티 채택이 증가함에 따라 연구 및 개발이 계속해서 가장 큰 부문이 될 것입니다.
• 지역별로는 북미가 전임상 연구량 증가와 캐나다의 연구 및 혁신에 대한 정부 보조금 증가로 인해 북미가 가장 규모가 큰 지역이 될 것으로 보입니다.

전임상 in-vivo 이미징 시장의 전략적 성장 기회

전임상 in-vivo 이미징 부문은 다양한 용도에서 전략적 성장 기회가 존재하는 것이 특징입니다. 기술 혁신과 연구 활동 증가로 성장 잠재력은 지속되고 있습니다.

• 이미징 양식의 확장: 멀티모달 시스템의 획득은 전임상 연구를 발전시킬 수 있는 길을 제시합니다. 이 전략은 복잡한 세포 현상과 질병 병태에 대한 상세한 조사가 가능하여 치료법 개발에 새로운 길을 열어줄 것입니다.
• 이미징 프로세스에서 이미징 시스템용 AI 개발: 성장 기회가 높은 또 다른 이미지 분석 분야는 이미지 데이터 활용을 강화하는 AI 이미지 분석입니다. 다양한 연구에 따르면 AI를 영상 처리에 적용하면 조사 방법을 개선하고 질병 과정과 치료에 대한 반응을 더 잘 이해할 수 있다고 합니다.
• 비용 효율적인 이미징 솔루션 개발: 비용 효율적인 이미징 솔루션의 구축은 특히 전임상 연구에서 저비용으로 사용하기 쉬운 이미징 기술에 대한 수요에 부응하는 것입니다. 더 저렴한 시스템, 더 쉽게 사용할 수 있는 시스템은 연구 역량을 향상시키고 더 많은 기관에서 연구를 수행할 수 있게 해줄 수 있습니다.
• 휴대용 이미징 기술의 성장: 휴대용 이미징 기술의 발명은 유연성과 가용성으로 인해 연구의 가능성을 넓혀줍니다. 휴대용 시스템은 소규모 실험실이나 현장 연구 등 다양한 수준의 생체내 이미징을 가능하게 하여 전임상 연구의 폭을 넓혀줍니다.
• 실시간 이미징의 혁신 : 실시간 이미징은 역동적인 생물학적 과정을 지속적으로 평가하여 새로운 방법을 개발하고 추가 개발을 가능하게 합니다. 이를 통해 세포 기능 및 질병에 대한 연구개발을 쉽게 추적할 수 있으며, 연구 및 치료 방법을 강화할 수 있습니다.

이러한 성장 기회는 공통성의 원칙, 접근의 용이성, 기술의 풍부함 등으로 인해 전임상 in-vivo 이미징 개발에 놀라운 잠재력을 가지고 있습니다. 이러한 부문에 대한 접근은 연구 발전과 개선에 도움이 될 것입니다.

전임상 in-vivo 이미징 시장 성장 촉진요인 및 과제

전임상 in-vivo 이미징 시장에 영향을 미치는 요인은 기술적 요인, 경제 상황, 규제 등 다양합니다. 시장 탐색을 돕고 성장을 지원하기 위해 알아야 할 요소도 있습니다.

전임상 in-vivo 이미징 시장을 주도하는 요인은 다음과 같습니다.

• 기술 발전: 실시간 이미징 및 멀티모달 이미징 기술 등 이미징 시스템 관련 기술의 성장은 전임상 in-vivo 이미징의 확장을 촉진하고 있습니다. 이러한 변화는 이미징 툴의 능력, 정확성, 가능성을 향상시켜 보다 심층적인 연구를 가능하게 합니다.
• 고해상도 이미징에 대한 수요 증가: 복잡한 생물학적 과정의 활동과 병원체에 의한 상호작용을 탐색하는 데 사용되는 고해상도 이미징의 성장이 여전히 주요 요인으로 작용하고 있다는 점을 염두에 두어야 합니다. 따라서 단순한 이미징 기술을 통한 전임상 검사보다는 더 깊은 인사이트를 제공하는 첨단 이미징 기술을 통한 전임상 검사가 이루어지고 있습니다.
• 비용 효율적인 솔루션 개발: 저렴한 가격의 이미징 솔루션의 개발은 이러한 기술의 보급을 확대하고 시장 성장을 가속하는 요인으로 작용하고 있습니다. 저렴한 이미징 장비를 사용할 수 있게 됨에 따라 자원에 제약이 있는 환경을 포함하여 모든 상황에서 연구를 쉽게 도입하고 추진할 수 있게 되었습니다.
• 규제 및 컴플라이언스 요건: 규제에 대한 우려와 안전 지침은 시장 성장에 매우 중요합니다. 필요한 규제 기준을 충족하는 이미징 기술만이 시장에 유통되어 안전성과 효율성을 높일 수 있습니다.

전임상 in-vivo 이미징 시장이 해결해야 할 과제는?

• 경쟁 시장 역학: 전임상 in-vivo 이미징 시장은 그 특성상 경쟁이 매우 치열합니다. 또한 기업은 관련성을 유지하고 연구 수요를 충족시키기 위해 시장에서 제품을 혁신하고 재배치해야 합니다.
• 첨단 기술의 높은 비용: 이러한 첨단 이미징 기술의 대부분은 비용이 많이 드는 경향이 있으며, 특히 소규모 연구기관이나 자금이 제한된 지역에서는 그 보급을 방해하는 요인으로 작용하고 있습니다. 이러한 비용은 새로운 이미징 시스템의 도입과 이용에 영향을 미칠 수 있습니다.
• 기술적 복잡성 및 통합 문제: 첨단 영상 처리 시스템의 기술적 복잡성과 새로운 구성 요소를 통합할 때 발생하는 예상치 못한 문제는 현장에서의 성공 여부를 좌우할 수 있습니다. 즉, 기술과 운영 모두 현장 배포 및 성능의 성공을 저해하지 않을 정도로 직관적이어야 합니다.

이러한 시장 성장 촉진요인 및 과제는 전임상 in vivo 이미징 시장과 어떻게 상호 작용하는가? 성장세는 기술 개발과 수요에 의해 지원되고 있지만, 시장 범위는 비용, 규제, 시장 경쟁에 의해 제한되고 있습니다. 이러한 과제를 성공적으로 극복하고 동시에 산업이 원하는 결과에 도달하기 위한 추진력을 활용하는 것이 중요합니다.

목차

제1장 개요

제2장 세계의 전임상 in-vivo 이미징 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 산업 촉진요인과 과제

제3장 2019-2031년 시장 동향과 예측 분석

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 전임상 in-vivo 이미징 시장 동향(2019-2024년)과 예측(2025-2031년)
• 유형별 세계의 전임상 in-vivo 이미징 시장
  • 광학 이미징
  • 핵이미징
  • MRI 조영제
  • 초음파 조영제
  • CT 조영제
• 모달리티별 세계의 전임상 in-vivo 이미징 시장
  • 광학 영상 시스템
  • 전임상 핵이미징 시스템
  • 마이크로 MRI 시스템
  • 마이크로 초음파 시스템
  • 마이크로 CT 시스템
  • 전임상 광음향 이미징 시스템
  • 전임상 자기 입자 이미징(MPI) 시스템
• 용도별 세계의 전임상 in-vivo 이미징 시장
  • 연구개발
  • Drug Discovery
• 유통 채널별 세계의 전임상 in-vivo 이미징 시장
  • 제약회사
  • 바이오테크놀러지 기업
  • 연구기관
  • 기타

제4장 2019-2031년 지역별 시장 동향과 예측 분석

• 지역의 전임상 in-vivo 이미징 시장
• 북미의 전임상 in-vivo 이미징 시장
• 유럽의 전임상 in-vivo 이미징 시장
• 아시아태평양 전임상 in-vivo 이미징 시장
• 기타 지역 전임상 in-vivo 이미징 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 유형별 세계의 전임상 in-vivo 이미징 시장의 성장 기회
  • 모달리티별 세계의 전임상 in-vivo 이미징 시장의 성장 기회
  • 용도별 세계의 전임상 in-vivo 이미징 시장의 성장 기회
  • 유통 채널별 세계의 전임상 in-vivo 이미징 시장의 성장 기회
  • 지역별 전임상 in-vivo 이미징 시장의 성장 기회
• 세계의 임상전 in-vivo 이미징 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 전임상 in-vivo 이미징 시장의 능력 확대
  • 세계의 전임상 in-vivo 이미징 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 개요

• Bruker Corporation
• Siemens
• TriFoil Imaging
• PerkinElmer
• VisualSonics

영문목차

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.5 billion by 2031 with a CAGR of 6.2% from 2025 to 2031. The major drivers for this market are the growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

• Lucintel forecasts that, within the modality category, micro-ultrasound systems segment is expected to witness the highest growth over the forecast period.
• Within the application category, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.
• In terms of region, North America will remain the largest region due to the increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Preclinical In-Vivo Imaging Market

The sphere of preclinical in-vivo imaging is advancing with a few emerging trends that are overhauling the research and the development activities. The preclinical in-vivo imaging process is characterized by the inclusion of novel technologies or techniques which improve the modalities used.

• Integration of Multimodal Imaging: Interventional and multimodal imaging has led to an increasing trend in imaging systems where PET, MRI and CT techniques are integrated together. Such systems enhance the knowledge regarding the regularity of biological processes, and elucidate pathways that are likely to be disrupted in disease states due to the ability to capture anatomic, functional and molecular processes concurrently.
• Advancement in Contrast Agents and Probes: There is an improved efficiency of in-vivo imaging procedures because of new imaging agents and new types of imaging probes. Preclinical target evaluation and diagnostics may benefit from such innovations because they enable the assessment of the disease process and the efficacy of therapeutic agents on a cellular and molecular level more so than previously possible.
• Utilization of Artificial Intelligence: There has been an increasing adoption of systems that use images and incorporate the application of attention AI that is used for imaging enhancement and interpretation of results. Big data from imaging studies can be analyzed by the machine and produce statistically significant biomarkers where human intelligence is limited significantly improving the quality and pace of research.
• Emergence of Portable Imaging Systems: The portable and compact imaging modalities are maturing and are being utilized in preclinical investigations. Such systems are versatile and allow the possibility of in-vivo imaging in conventional laboratories or field settings without degrading the quality of imaging.
• Advances in Real-Time Imaging: Continuous imaging techniques enhance the prospects of real-time monitoring of biological processes as they occur as opposed to destructive sampling methods. New imaging modalities especially optical and fluorescence have breached the barriers of resolution and temporal limitations to allow time-lapse imaging of cellular events and processes, thus unveiling disease pathology and therapeutic strategies.

These trends are driving significant progress in preclinical in-vivo imaging by praising the level of analysis, facilitating the acquisition of imagery, and getting more work done in quicker times. They are changing the processes by which diseases are studied and new remedies are created by the investigators.

Recent Developments in the Preclinical In-Vivo Imaging Market

There is ever increasing transformation in research capabilities and understanding of biological processes through the recent developments in preclinical in-vivo imaging. Employment of various technologies and improvement of existing methodologies that make research accurate, targeting and within shorter periods are important features of, recent technology advancement.

• Enhanced Multimodal Imaging Systems: Today's multimodal imaging systems involve the combination of previously disparate imaging techniques such as PET, MRI, and CT. This facilitates a multi-faceted approach to the study of biological processes and the acquisition of anatomical, functional and molecular information that will help to resolve some of the challenges posed by preclinical research.
• Advanced Contrast Agents and Probes: The latest imaging contrast agents and imaging probes are increasing the efficacy of in-vivo imaging. These developments allow researchers to demonstrate better targeting of, and distinguish between, various cellular and molecular species, thus improving the study of disease mechanisms and treatment efficiency.
• AI-Driven Image Analysis: The application of artificial intelligence (AI) specifically in image analysis is one of the notable aspects of development. AI algorithms assist in the acquisition and analysis of a large amount of imaging data, allowing gaining of high precision information and expanding the effectiveness to research diagnosis.
• Development of Portable Imaging Technologies: In recent years, there has been a remarkable progress in the use of non-invasive imaging technologies. These systems are efficient due to their flexibility for application in both smaller research laboratories and in the field, thus enhancing the advanced imaging and flexibility to the diverse needs of research.
• Recent Developments in Real-Time Imaging: Here are developments in real-time imaging techniques like highly-resolution optical imaging and fluorescence imaging that aid to continuous observation of biological activities. These techniques give a dynamic view of cellular processes and development of disease, thereby improving the understanding of treatment outcomes and disease processes.

These developments are advancing the field of preclinical in-vivo imaging by technology improvement, enhancing accessibility and expanding research efforts. New tools and methodologies being adopted are facilitating advancement in the understanding of biological systems and the creation of new therapies.

Strategic Growth Opportunities for Preclinical In-Vivo Imaging Market

The sector of preclinical in-vivo imaging is characterized by presence of several strategic growth opportunities in various applications. Growth potentials are persist because of technology innovations and increasing research activity.

• Extension of Modalities for Imaging: The acquisition of multimodal one systems present an avenue of advancing preclinical studies since improving these imaging techniques incorporate more than one. This strategy enhances an in-depth investigation of complicated cellular events and disease pathology, thus offering new avenues in therapy development.
• Development of AI for Imaging System in Imaging Process: Another area of imaging analysis which has a high growth opportunity is AI Imaging Analysis wherein the uses of imaging data are enhanced. Various studies show how AI application on imaging will help improve research processes and even enhance the understanding of disease processes and responses to treatment.
• Development of Cost-Effective Imaging Solutions: The creation of cost-effective imaging solutions meets the demand for imaging technologies that are both low-cost and easy to use, especially in preclinical research. Less expensive systems and greater availability may increase the capacity of research and allow for research to be conducted in a greater number of institutions.
• Growth in Portable Imaging Technologies: The invention of portable imaging technologies extends the possibilities of research through its flexibility and availability. Portable systems permit the performance of in-vivo imaging at various levels such as small labs and fieldwork thus broadening the preclinical scope of investigations.
• Innovations in Real-Time Imaging: Real-time imaging does develop new ways by continuous asses of dynamic biological processes it allows further growth. This makes it easy to track cellular functions and developments in diseases and thus enhance research and therapy methods.

These growth opportunities present amazing potential for the development of preclinical in-vivo imaging in recall of the principles of commonality and, the accessibility and which are richer in technology. Addressing these areas will help in attaining progress and improvement of research.

Preclinical In-Vivo Imaging Market Driver and Challenges

The factors affecting the preclinical in-vivo imaging market are quite a number, technological factors, economic conditions and regulations among others. There are elements which a person should know and they include assistance in the market navigation as well as help in growth.

The factors responsible for driving the preclinical in-vivo imaging market include:

• Technological Advancements: Growth of technologies in regards to the imaging systems such as real time and multimodal imaging technologies is promoting expansion of the preclinical in-vivo imaging. These changes enhance imaging tools' ability, precision, and potential to create research that is more detailed.
• Increasing Demand for High-Resolution Imaging: It is important to note that the growth in high-resolution imaging, used to explore the activities of complex biological processes and pathogen-induced interactions, remains the major factor. Therefore, no more preclinical studies are performed with simple imaging techniques, but with advanced imaging technologies providing deeper insights.
• Development of Cost-Effective Solutions: The development of affordable imaging solutions is a factor spurring growth of the market by expanding the reach of such technologies. The availability of inexpensive imaging equipment makes it easier to incorporate and promote research in all settings including those with resource constraints.
• Regulatory and Compliance Requirements: Regulatory concerns and safety guidelines are crucial for the growth of the market. Only those imaging technologies that meet the necessary regulatory standards are distributed into the market to enhance safety and efficiency, both critical for large-scale use.

Challenges in the preclinical in-vivo imaging market are:

• Competitive Market Dynamics: It is the nature of the market for preclinical in-vivo imaging that makes it worse as it is a very competitive one. Moreover, there is a need for companies to innovate and reposition their products in the market to remain relevant and meet research demands.
• High Costs of Advanced Technologies: Most of these advanced imaging technologies tend to be cost prohibitive which constitutes a hindrance to their scope especially in the case of smaller research institutions or in areas with limited funds. Such costs can influence the uptake and utilization of new imaging systems.
• Technical Complexity and Integration Issues: The technical complexity of advanced imaging systems and unforeseen challenges of incorporating new components can perhaps determine the success of such systems in the field. This means that both the technology and the operation must be intuitive to the extent that they do not inhibit successful deployment and performance in the field.

How these drivers and challenges interact preclinical in vivo imaging market. The growth is supported by the technology development and demand but market scope is limited by cost, regulatory, exchange, and competition. It will be important to overcome these challenges successfully and at the same time take advantage of drivers to reach the desired outcome in the industry.

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, preclinical in-vivo imaging companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

• Bruker Corporation
• Siemens
• Trifoil Imaging
• PerkinElmer
• Visualsonics

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging market by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Optical Imaging
• Nuclear Imaging
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Analysis by Value from 2019 to 2031]:

• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Research & Development
• Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Others

Preclinical In-Vivo Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Preclinical In-Vivo Imaging Market

With recent improvements in preclinical in vivo imaging, remarkable changes have been noted in the areas of drug development, disease modeling, and biological studies. Such developments are improving the processes of observing and assessing living animals to incorporate the findings into the inventions. Important areas like the US, China, Germany, India, and Japan have been handing help with these improvements in terms of technology and more research.

• United States: Within the U.S., there is a growing trend of applying combined imaging systems such as PET, MRI, and CT, which are favorable because the imaging in animal models is more efficient. Furthermore, the introduction of novel imaging agents and imaging molecules is enhancing the in vivo imaging such that much more detail on the bodily operation and the development of the pathology can be obtained.
• China: China is keeping pace with the development of advanced in vivo imaging systems and seeks high-resolution imaging and monitoring without delay. Focus has been made on developing advanced optical imaging systems and imaging software capable of visualizing cellular and molecular nucleocytoplasmic trafficking in response to defined stimuli with high precision. There is also an inclination towards the use of artificial intelligence (AI) in the analysis and interpretation of images.
• Germany: Germany has added additional new inventions for imaging technologies, for example, high-field MRI and sophisticated fluorescence systems. This has been making it possible for researchers to get even better spatial resolution and visualization of more complex biological processes. Germany is also at the forefront of the quest for new imaging systems combining several imaging modalities in one unit to facilitate studies in vivo Yours.
• India: In India, there is a rising focus on making the preclinical in-vivo imaging systems more advanced as well as more cost effective. The other most recent advancements also include the use of economical imaging systems and the creation of imaging facilities in research centers for drug discovery and disease studies. India is also working on increasing the number of international research organizations that will assist researchers in improving imaging technologies.
• Japan: Japan is taking the initiative in advancing the field of imaging with new inventions like the advanced near-infrared fluorescence imaging system and the high resolution optical imaging. With this, more molecular and cellular targets are being targeted and detected in live animals with the help of these cutting-edge technologies. Japanese researchers are now working on the incorporation of imaging technology and other biological research tools to achieve more profound in vivo findings.

Features of the Global Preclinical In-Vivo Imaging Market

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel, and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preclinical In-Vivo Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Preclinical In-Vivo Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Preclinical In-Vivo Imaging Market by Type
  • 3.3.1: Optical Imaging
  • 3.3.2: Nuclear Imaging
  • 3.3.3: MRI Contrast Agents
  • 3.3.4: Ultrasound Contrast Agents
  • 3.3.5: CT Contrast Agents
• 3.4: Global Preclinical In-Vivo Imaging Market by Modality
  • 3.4.1: Optical Imaging Systems
  • 3.4.2: Preclinical Nuclear Imaging Systems
  • 3.4.3: Micro-MRI Systems
  • 3.4.4: Micro-Ultrasound Systems
  • 3.4.5: Micro-CT Systems
  • 3.4.6: Preclinical Photoacoustic Imaging Systems
  • 3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
• 3.5: Global Preclinical In-Vivo Imaging Market by Application
  • 3.5.1: Research & Development
  • 3.5.2: Drug Discovery
• 3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 3.6.1: Pharmaceutical Companies
  • 3.6.2: Biotechnology Companies
  • 3.6.3: Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Preclinical In-Vivo Imaging Market by Region
• 4.2: North American Preclinical In-Vivo Imaging Market
  • 4.2.1: North American Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.2.2: North American Market by Application: Research & Development and Drug Discovery
• 4.3: European Preclinical In-Vivo Imaging Market
  • 4.3.1: European Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.3.2: European Market by Application: Research & Development and Drug Discovery
• 4.4: APAC Preclinical In-Vivo Imaging Market
  • 4.4.1: APAC Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.4.2: APAC Market by Application: Research & Development and Drug Discovery
• 4.5: ROW Preclinical In-Vivo Imaging Market
  • 4.5.1: ROW Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.5.2: ROW Market by Application: Research & Development and Drug Discovery

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
  • 6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
  • 6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
• 6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bruker Corporation
• 7.2: Siemens
• 7.3: TriFoil Imaging
• 7.4: PerkinElmer
• 7.5: VisualSonics